Shares on the Copenhagen bourse ended the trading day higher on Wednesday, with the OMX Copenhagen 20 finishing up 1.88% to register a new one-month high.
Broad sector strength in Consumer Goods, Oil & Gas and Healthcare helped drive the market advance.
Top performers
- Genmab (CSE:GMAB) led gains on the OMX Copenhagen 20, surging 29.06% - an increase of 871.00 points - to close at 3,868.00. The stock rose to an all-time high during the session.
- Vestas Wind Systems A/S (CSE:VWS) added 2.64%, a gain of 5.00 points, closing at 192.70.
- AL Sydbank A/S (CSE:ALSYDB) was up 2.45%, or 17.00 points, to finish at 712.00.
Largest decliners
- Novo Nordisk A/S (CSE:NOVOb) was the biggest laggard among the named names, falling 1.73% - down 4.50 points - to end the session at 255.00.
- Oersted AS (CSE:ORSTED) declined 1.02%, a loss of 1.35 points, to close at 131.10.
- Novozymes AS (CSE:NSISb) slipped 0.81%, down 3.80 points, to 465.20 at the close.
Market breadth on the Copenhagen Stock Exchange was positive: 64 stocks rose, 53 declined and 16 finished unchanged.
Commodities and currencies
Energy commodities were stronger in U.S. and European futures trading. Crude oil for December delivery rose 3.46%, gaining 3.46 to $103.36 a barrel. Brent for January delivery increased 2.68%, up 2.93 to $112.34 a barrel.
In metals, the December Gold Futures contract fell 0.53%, a decline of 21.60, to trade at $4,053.00 a troy ounce.
On the currency front, USD/DKK was down 0.19% at 6.70, while EUR/DKK was essentially unchanged, moving 0.04% to 7.47. Separately, the US Dollar Index Futures was reported down 0.05% at 102.11.
Notable data points and tickers mentioned
- OMXC20: +1.88%
- GMAB: +29.06%
- VWS: +2.64%
- ALSYDB: +2.45%
- NOVOb: -1.73%
- ORSTED: -1.02%
- NSISb: -0.81%
- CL (Crude): +3.46%
- LCO (Brent): +2.68%
- GC (Gold): -0.53%
- DX (US Dollar Index Futures): -0.05% (102.11)
Summary
The closing session in Copenhagen was dominated by gains across sectors tied to Consumer Goods, Oil & Gas and Healthcare, pushing the OMX Copenhagen 20 higher and lifting several individual names, most notably Genmab, which reached an all-time peak. Energy markets showed strength with higher crude and Brent futures, while gold futures declined and the U.S. dollar softened slightly versus the Danish krone.